The Bombay Stock Exchange in Mumbai, India (Photographer: Dhiraj Singh/Bloomberg)
Live: Sensex, Nifty Hold On To Gains; UPL Surges 16%
Stock Update: Glenmark Pharma
- Trades at a three-month high
- Top gainer on the Nifty Pharma index
- Second highest gainer on the Nifty Midcap index
- Gains for the sixth straight session
- Back to back days of over 10 percent gains
- Up over 60 percent in the last six sessions
- Best six-day rally on record
- The stock today has gained on high volumes
- Volumes today are 5.2 times higher than its 30-day average
- Relative Strength Index (RSI) at 74. A reading above 70 indicates stock is overbought
- Has doubled from its 52-week low of Rs 168 on March 13, 2020
- 20 out of the 32 analysts tracking the stock have a buy recommendation
- Return potential for the stock as per Bloomberg data is 13 percent
Markets At Noon
- Benchmark indices off day's high but holding on to gains
- Nifty up 2.2 percent at 9,193
- Sensex up 2 percent at 31,327
- Nifty Bank up 2.1 percent at 19,904
- Nifty Midcap Index up 3 percent
- Nifty Smallcap Index up 3.3 percent
- India Volatility Index down 4.74 percent to 49
- All sectoral indices trade with gains
- Nifty FMCG index top sectoral gainer; up 4.2 percent
- Nifty Pharma and Nifty Metal up 3 percent each
- Nifty I.T., Nifty PSU Bank and Nifty Realty up 2 percent
- UPL remains the top Nifty gainer; up 15.6 percent
- Kotak Mahindra Bank top Nifty loser; down 1 percent
- 1,458 stocks are advancing while 283 are trading with losses
Nifty FMCG: Top Sectoral Gainer
Stock Update: Sanofi India
- Trades at an all-time high
- Gains as much as 10.4 percent to Rs 7,961
- Biggest one-day gain since September 2014
- Up in 7 out of the last 10 trading sessions
- Up close to 30 percent in the last 10 trading sessions
- Best 10-day return since June 2000
- The stock has gained today on strong volumes
- Volumes are 3 times higher than its 30-day average
- 11 out of the 13 analysts tracking the stock have a buy recommendation
- The stock is trading 3.4 percent higher than its 12-month Bloomberg Consensus target of Rs 7,536